LifeScale自动化快速表型药敏试验直接用于阳性血培养革兰阴性杆菌的性能评估
本研究评估LifeScale微流控传感器快速表型药敏系统,直接以阳性血培养中的革兰阴性杆菌为对象,在临床条件下与现行标准药敏系统比较。结果显示LifeScale易用,可在5小时内提供快速、可靠、准确的药敏结果,对混合培养也显示耐药结果。若进一步验证稳健,或可无需额外确认试验即报告快速结果。
要点
- LifeScale直接用于阳性血培养革兰阴性杆菌,5小时内可获快速可靠药敏结果。
- 混合培养中任一分离株耐药时,LifeScale即报告耐药结果。
- 若结果稳健,或可无需额外确认试验报告快速LifeScale结果。
核心结论
- LifeScale直接用于阳性血培养革兰阴性杆菌,可在5小时内提供快速、可靠、准确的药敏结果,与现行标准药敏系统总体一致性良好,尤其分类一致性。
研究设计与样本
- 本研究为基于临床的评估研究,将LifeScale微流控传感器快速表型药敏系统与现行标准药敏系统在临床条件下比较,对象为阳性血培养中的革兰阴性杆菌。
主要发现
- LifeScale易用,可在5小时内直接自阳性血培养提供快速、可靠、准确的药敏结果,覆盖当前数据库所列革兰阴性菌。
- 对于涉及混合培养的所有菌-抗生素组合,当任一混合分离株耐药时,LifeScale显示耐药结果。
- LifeScale结果与标准药敏系统总体一致性良好,尤其分类一致性。
关键数值与推荐
- LifeScale可在5小时内直接自阳性血培养提供药敏结果。
临床怎么用
- LifeScale可直接用于阳性血培养革兰阴性杆菌的快速药敏检测,有助于尽早选择适当抗生素及靶向治疗。
- 若进一步测试证实结果稳健,或可无需额外确认试验即报告快速LifeScale结果。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Rapid antimicrobial susceptibility testing (rAST) performed directly from blood cultures is essential to influencing the selection of appropriate antibiotics, preferably targeted therapy, for the treatment of bloodstream infections. Affinity Biosensors has developed the LifeScale, a phenotypic rAST system based on microfluidic sensors with a mechanical resonator that measures the mass of individual microbes. The combination of replication, biomass, and population profiling of individual microbes is analyzed to produce rAST results. The performance of the LifeScale was evaluated and compared to our current standard of care (SOC) antimicrobial susceptibility testing (AST) system under clinical conditions. The results indicated that the LifeScale is easy to use and provides rapid, reliable, and accurate AST results in less than 5 h directly from from positive blood cultures containing Gram-negative organisms listed in the current database. For all organism-antibiotic combinations involving polymicrobial cultures, LifeScale showed a resistant result when either mixed isolate was resistant. If these results prove to be robust on further testing, this may justify the reporting of rapid LifeScale results without the need for additional confirmatory testing. IMPORTANCE: This is the first clinical-based study of a unique technology using microfluidic sensors to generate rapid antimicrobial susceptibility test results directly from blood cultures containing Gram-negative rods. The issue of polymicrobial cultures was also addressed in this study, which, to our knowledge, has not been addressed in publications of other rapid phenotypic AST systems. Overall, LifeScale results compared favorably with the SOC in terms of overall agreement, especially categorical agreement.
引用
- Snyder JW, Chaudhry N, Hoffmann W, et al. Performance of the LifeScale automated rapid phenotypic antimicrobial susceptibility testing on Gram-negative rods directly from positive blood cultures. J Clin Microbiol. 2024. PMID: 39480069. doi:10.1128/jcm.00922-24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。